Icosapent ethyl: safely reducing cardiovascular risk in adults with elevated triglycerides-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Icosapent ethyl: safely reducing cardiovascular risk in adults with elevated triglycerides

Published:2021-09-07 Issue:1 Volume:21 Page:31-42
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Pareek Manan¹²³,Mason R. Preston¹⁴,Bhatt Deepak L.¹^ORCID

Affiliation:

1. Heart & Vascular Center, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

2. Department of Internal Medicine, Yale New Haven Hospital, Yale University School of Medicine, New Haven, CT, USA

3. Department of Cardiology, North Zealand Hospital, Hillerød, Denmark

4. Elucida Research LLC, Beverly, MA, USA

Funder

Amarin Pharma, Inc

Publisher

Informa UK Limited

Subject

Pharmacology (medical),General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14740338.2021.1954158

Reference128 articles.

1. The Burden of Cardiovascular Diseases Among US States, 1990-2016

2. Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association

3. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical results and mechanism of action of icosapent ethyl;European Heart Journal Supplements;2023-04-01

2. Dyslipidemia Treatment and Lipid Control in US Adults with Diabetes by Sociodemographic and Cardiovascular Risk Groups in the NIH Precision Medicine Initiative All of Us Research Program;Journal of Clinical Medicine;2023-02-20

3. Emphasis on Icosapent Ethyl for Cardiovascular Risk Reduction: A Systematic Review;Cureus;2022-12-09

4. Prevention of Cardiovascular Events and Mortality With Icosapent Ethyl in Patients With Prior Myocardial Infarction;Journal of the American College of Cardiology;2022-05

5. Treatment With Icosapent Ethyl to Reduce Ischemic Events in Patients With Prior Percutaneous Coronary Intervention: Insights From REDUCE‐IT PCI;Journal of the American Heart Association;2022-03-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3